无家可归者的痴呆症护理和死亡率:一个匹配的队列研究
Salimah Z Shariff1,2, Melody Lam1, Monidipa Dasgupta3,4
1ICES Western, London Health Sciences Centre Research Institute, London Health Sciences Centre, London, Ontario, Canada.
概括
患有痴呆症的无家可归者面临更高的死亡率和护理差距. 连接卫生,社会服务和住房的综合护理模式对于这个弱势群体至关重要.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 痴呆症不成比例地影响那些经历无家可归的人.
- 有限的了解存在关于痴呆症护理和死亡率在这个人口的诊断后.
研究的目的:
- 为了比较痴呆症护理,服务利用率和诊断后一年内无家可归者和住房人士之间的死亡率.
- 识别痴呆症无家可归者在医疗保健获取和结果方面的差异.
主要方法:
- 在加拿大安大略省进行了匹配的队列研究,比较了559名无家可归者和2002名住房的新被诊断患有痴呆症的人.
- 根据年龄,性别,诊断日期和健康区域进行匹配.
- 比较痴呆症护理,长期护理入院,医疗服务使用和死亡率.
主要成果:
- 与住房的个人相比,无家可归的人的长期护理入院率和死亡率更高.
- 无家可归的人较少接受胆酶抑制剂.
- 在无家可归者群体中观察到,在没有急性护理需求的情况下,急诊室和医院病床日的使用率增加.
结论:
- 患有痴呆症的无家可归者经历了更高的死亡率和显著的护理差距.
- 需要综合护理模式,结合医疗保健,社会服务和住房支持.
- 大多数患有痴呆症的无家可归者在诊断后的一年内没有被安置在长期护理中,这凸显了未得到满足的需求.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
985
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
985
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
Stereotype Content Model
14.9K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
14.9K
Continuing Care
1.6K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K


